Savitz Ryan (CIK 1992324) reported 20 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-13). Recent activity: Buy DNTH (31,249 shares), Sell DNTH (10,354 shares), Sell DNTH (15,329 shares), Sell DNTH (5,566 shares), Buy DNTH (8,224 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Buy | 31,249 | $680,291 |
| 2026-07-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Sell | 10,354 | $1.0M |
| 2026-07-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Sell | 15,329 | $1.6M |
| 2026-07-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Sell | 5,566 | $567,565 |
| 2026-04-10 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Buy | 8,224 | $147,045 |
| 2026-04-10 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Sell | 8,224 | $738,844 |
| 2026-04-01 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Buy | 74,367 | $627,657 |
| 2026-04-01 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Buy | 40,000 | $715,200 |
| 2026-04-01 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Sell | 1,390 | $108,879 |
| 2026-04-01 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Sell | 21,825 | $1.7M |
| 2026-04-01 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Sell | 1,485 | $119,171 |
| 2026-04-01 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Sell | 800 | $65,088 |
| 2026-04-01 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Sell | 2,366 | $195,999 |
| 2026-04-01 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Sell | 59,800 | $5.0M |
| 2026-04-01 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Sell | 19,469 | $1.6M |
| 2026-04-01 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | EVP, CFO & CBO | Sell | 7,232 | $618,625 |
| 2025-12-05 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CFO & CBO | Buy | 20,000 | $168,800 |
| 2025-12-05 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CFO & CBO | Sell | 20,000 | $903,600 |
| 2025-09-11 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CFO & CBO | Buy | 20,000 | $168,800 |
| 2025-09-11 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CFO & CBO | Sell | 20,000 | $700,000 |
Source: SEC Form 4 filings · as of 2026-07-13